Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Panbela Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 11 | 0 | −11 |
| Shares | 152.0K | 0 | −152.0K (−100.0%) |
| Value | $115.8K | $0 | −$115.8K (−100.0%) |
New holders (0)
Institutions that held Panbela Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
None.
Sold out (11)
Institutions that held Panbela Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| HRT Financial LP | 38,144 | $34.0K |
| Citadel Advisors LLC | 34,211 | $31.3K |
| Geode Capital Management, LLC | 15,886 | $14.5K |
| Tower Research Capital LLC (TRC) | 15,015 | $13.7K |
| JPMorgan Chase & Co | 12,451 | $11.4K |
| Two Sigma Securities, LLC | 11,689 | $10.7K |
| Advisor Group Holdings, Inc. | 70 | $63 |
| Wells Fargo & Company | 39 | $36 |
| Morgan Stanley | 10 | $9 |
| Bank of America Corp | 2 | $2 |
| Goldman Sachs Group Inc | 24,513 | – |